English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc ([...

$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc (MNPR  Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading upgraded the rating on the stock to a Buy and gave it a $2.00 price target.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
5817 Views
Comment
Sign in to post a comment
    61
    Followers
    39
    Following
    522
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    Unlock Now

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.